Venous aneurysms: When should we intervene?

External Jugular Venous Aneurysm -- A Case Report

“…Approximately 500 cases of venous aneurysms have been reported [2] to date, and to our knowledge, no standardised guidelines for management exist.…”

“…There is no consensus on how to manage these lesions, with asymptomatic cases usually managed conservatively following consideration of the risks of rupture, bleeding and VTE from the aneurysm as well as cosmetic concerns. Surgical excision is possible, but the risks would include bleeding, thrombophlebitis, damage to the nerves, wound complications, and recurrence [2] . We present the case of a 37-year-old woman who had an aneurysm of the external jugular vein which was treated surgically.…”

Venous aneurysms: To treat or not to treat

“…I read with great interest the editorial by Cruddas et al 1 that was published recently and wanted to congratulate the authors for their contribution to the subject.…”

“…

I read with great interest the editorial by Cruddas et al 1 that was published recently and wanted to congratulate the authors for their contribution to the subject.These aneurysms are indeed rare and little is known about their natural history. Because of their rarity, little consensus exists about their management.

…”

Comparison of tissue biomarkers in arterial and vein (arteriovenous fistula) aneurysms

“…4 The treatment of venous aneurysms is still debatable, and the necessity for surgery must take into account the possibility of thromboembolic or hemorrhage problems. 5 In general, require more studies in the field of prevention, diagnosis, and treatment compared to aortic aneurysm, biomarkers are usually popular in the field of prevention and treatment since they can contribute significantly to prevention, diagnosis, and treatment with the least cost and risk. 6 While each of these measures represents a biomarker, the word has evolved to mean a new protein, cytokine, or enzyme having a discriminating value in clinical treatment.…”